Skip to main content
Premium Trial:

Request an Annual Quote

NIH Sets Aside $6M for Genomic Technology Development in FY 2007

NEW YORK, June 19 (GenomeWeb News) - the National Institutes of Health has set aside $6 million in funding for the 2007 fiscal year to support technology development related to The Cancer Genome Atlas pilot project that kicked off in late 2005.


The goal of the genomic technology is to "inspire and promote the development of highly innovative tools and new ways to interrogate genomic alterations in cancer, NIH said.


The emphasis is on new high-resolution, high-throughput technologies to detect alterations in the cancer genome, epigenome, or transcriptome, "including, but not limited to: changes in DNA segment copy numbers, translocations, loss of heterozygosity, epigenomic modifications, and aberrant gene expression profiles."


In a notice issued Friday, titled, "Selection of Funding Opportunities for the Technology Component of the Cancer Genome Atlas (TCGA) Project," NIH outlined three separate funding opportunities under the initiative:



The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more